CRIS Current Research Information System

ANDRISANO, VINCENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.446
AS - Asia 17.116
EU - Europa 13.478
AF - Africa 979
Continente sconosciuto - Info sul continente non disponibili 940
SA - Sud America 938
OC - Oceania 35
Totale 51.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.124
CN - Cina 4.720
SG - Singapore 4.402
VN - Vietnam 4.287
IT - Italia 3.335
GB - Regno Unito 3.096
DE - Germania 1.587
SE - Svezia 1.120
HK - Hong Kong 1.058
UA - Ucraina 960
IN - India 870
FR - Francia 811
RU - Federazione Russa 692
BR - Brasile 659
IE - Irlanda 411
KR - Corea 393
JP - Giappone 336
CI - Costa d'Avorio 321
BD - Bangladesh 267
NL - Olanda 257
ZA - Sudafrica 249
EE - Estonia 230
FI - Finlandia 182
CA - Canada 178
TG - Togo 148
SC - Seychelles 138
BG - Bulgaria 120
CH - Svizzera 120
AR - Argentina 115
ES - Italia 107
ID - Indonesia 98
PH - Filippine 87
PL - Polonia 86
TR - Turchia 82
TH - Thailandia 69
JO - Giordania 68
MX - Messico 68
TW - Taiwan 63
BE - Belgio 59
HR - Croazia 54
IQ - Iraq 51
PK - Pakistan 51
IR - Iran 48
EC - Ecuador 45
GR - Grecia 44
CZ - Repubblica Ceca 43
EU - Europa 38
AT - Austria 36
CL - Cile 36
SA - Arabia Saudita 36
CO - Colombia 32
RO - Romania 30
AU - Australia 29
NG - Nigeria 22
DK - Danimarca 21
LB - Libano 19
DZ - Algeria 17
MA - Marocco 17
UZ - Uzbekistan 17
MY - Malesia 16
AE - Emirati Arabi Uniti 15
EG - Egitto 15
CR - Costa Rica 14
HN - Honduras 14
VE - Venezuela 14
PT - Portogallo 13
TN - Tunisia 13
PY - Paraguay 12
JM - Giamaica 11
KE - Kenya 11
GT - Guatemala 10
LT - Lituania 10
HU - Ungheria 9
IL - Israele 9
SI - Slovenia 9
AZ - Azerbaigian 8
BO - Bolivia 8
MD - Moldavia 8
NP - Nepal 8
PE - Perù 8
TT - Trinidad e Tobago 8
OM - Oman 7
SM - San Marino 7
LK - Sri Lanka 6
UY - Uruguay 6
AL - Albania 5
AO - Angola 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
ET - Etiopia 4
BH - Bahrain 3
CG - Congo 3
CM - Camerun 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
SN - Senegal 3
BB - Barbados 2
Totale 50.985
Salva come PNG Salva come JPEG
Città #
Singapore 3.028
Southend 2.612
Ashburn 1.974
Fairfield 1.324
Chandler 1.161
Hong Kong 981
San Jose 980
Ho Chi Minh City 978
Santa Clara 954
Hanoi 808
Hefei 802
Houston 783
Wilmington 745
Bologna 740
Jacksonville 673
Woodbridge 625
Dong Ket 619
Princeton 610
Seattle 564
Council Bluffs 539
Beijing 506
Ann Arbor 502
Cambridge 454
Boardman 414
Dublin 410
Abidjan 321
Seoul 303
Nanjing 293
Tokyo 287
Lauterbourg 286
Los Angeles 279
Westminster 267
Padova 263
Berlin 224
Dallas 222
New York 219
Milan 217
Jinan 197
Buffalo 163
Shenyang 151
Helsinki 150
Lomé 148
Medford 134
Da Nang 131
Saint Petersburg 130
Guangzhou 127
Turin 117
Changsha 116
Haiphong 116
Sofia 114
Mülheim 111
Rome 100
Redondo Beach 98
Falls Church 96
Tianjin 94
Nanchang 93
Hebei 90
Bengaluru 87
Shanghai 85
San Diego 84
Mahé 83
Cesena 80
Frankfurt am Main 78
Zhengzhou 76
Bern 74
São Paulo 74
Munich 73
Amman 68
Hải Dương 65
Dearborn 62
Jiaxing 61
Phoenix 59
Redmond 58
Bremen 56
Des Moines 54
Hangzhou 54
Biên Hòa 52
Rimini 52
Chicago 51
Haikou 50
San Francisco 50
Brussels 48
Carpi 48
Orem 48
Jakarta 46
Taiyuan 45
Norwalk 44
Verona 44
Brooklyn 43
Hyderabad 43
Warsaw 42
Forlì 41
London 41
Naples 40
Redwood City 40
Can Tho 39
Cardiff 39
Florence 38
Taizhou 38
Barcelona 37
Totale 31.833
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 543
A small molecule targeting the multifactorial nature of Alzheimer's disease 537
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 447
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 442
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 431
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 413
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 351
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 345
Analisi farmaceutica: metodi di riconoscimento e di separazione 331
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 326
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 300
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 299
Advanced analytical methodologies in Alzheimer's disease drug discovery 293
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 289
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 286
Analisi farmaceutica. Metodi di riconoscimento e di separazione 284
Influence of high-pressure homogenization treatments combined with lysozyme activated packaging on microbiological and technological quality of vegetable smoothie during shelf life 271
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: structure-based design, synthesis, and biological evaluation 261
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 256
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 255
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 251
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 243
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 237
Influence of an innovative, biodegradable active packaging on the quality of sunflower oil and “pesto” sauce during storage 231
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 226
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6 224
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 222
null 222
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 222
Rational Approach to discover multipotent anti-Alzheimer drugs 220
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer’s Disease 219
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 217
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 216
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 210
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues 209
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 208
Determination of levamisole and tetramisole in seized cocaine samples by enantioselective high-performance liquid chromatography and circular dichroism detection 207
Development of a new bio-compostable thin film for food packaging with in-line plasma treatment 207
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 207
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 205
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 204
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 201
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 201
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 200
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 200
Comprehensive amino acids profiling of microalgae by gas chromatography-mass spectrometry analysis after pre-column derivatization 198
EcoPackLab: a new laboratory for the development of new food packaging with long shelf life 197
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 197
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 195
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 190
AFM study of F-actin on chemically modified surfaces 189
Determination of dextromethorphan and levomethorphan in seized heroin samples by enantioselective HPLC and electronic CD 189
Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action 187
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 187
Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease 187
Choosing the right chromatographic support in making a new acetylcholinesterase-micro-immobilised enzyme reactor for drug discovery. 185
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 183
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease 183
Analytical characterization of fruits waste for their valorization as sources of bioactive compounds. 182
Monolytic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies 181
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimers Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography 181
Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorge 180
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 180
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease 180
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice 180
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties 179
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 178
Separation and quantitation of Fructose-6-phosphate and Fructose-1,6-diphosphate by LC-ESI-MS for the evaluation of Fructose-1,6-biphosphatase activity 177
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks 177
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 177
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases 177
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 176
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 175
AFM study of F-actin on chemically modified surfaces 175
Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. 175
Simultaneous micellar electrokinetic chromatography of adriblastina and tarabine PFS. Their application to some biological fluids. 173
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 173
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 173
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 173
GC-FID/MS method for the impurity profiling of synthetic d-allethrin. 172
METODI ANALITICI INTEGRATI PER LA VALUTAZIONE DEL PROFILO D’AZIONE DI NUOVI FARMACI ANTI-ALZHEIMER. 172
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 172
Characterization of reversible and pseudo-irreversible Acetylcholinesterase inhibitors by means of immobilized enzyme reactor 172
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 172
Methotrexate determination in pharmaceuticals by enantioselective HPLC 171
Batch-wise covalent immobilisation of human acetylcholinesterase: kinetic and inhibition spectrophotometric studies 171
Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets 171
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates 170
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 169
Phenolic and Antioxidant Characterization of Fruit By-Products for Their Nutraceuticals and Dietary Supplements Valorization under a Circular Bio-Economy Approach 168
CHOOSING THE RIGHT CHROMATOGRAPHIC SUPPORT FOR ENZYME-BASED MICRO-IMERS. 168
Design, Synthesis and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease Modifying Agents for Alzheimer's Disease 167
LC analysis of Oxytetracycline and Chlortetracycline: application for in vitro bio-equivalence study of veterinary medicines 167
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 166
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease 166
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 166
Preparation of (hetero)aromatic (hetero)cyclic carboxamides for the treatment of Alzheimer's disease 164
Stereoselective analysis of allethrin by two dimensional achiral/chiral HPLC with UV/circular dichroism detection 163
Human recombinant beta-secretase immobilized enzyme reactor for fast hits’ selection and characterization from a virtual screening library 163
1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies 163
Totale 22.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.603
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.718 0 186 279 319 455 338 128 383 276 403 1.021 930
2022/20235.460 581 728 305 712 375 386 140 347 902 229 461 294
2023/20242.466 122 291 169 200 189 359 268 402 72 121 154 119
2024/20256.772 318 1.025 707 456 1.337 347 494 270 92 323 287 1.116
2025/202617.064 1.446 1.927 1.632 1.371 1.863 1.009 2.125 481 2.716 991 714 789
2026/2027840 380 460 0 0 0 0 0 0 0 0 0 0
Totale 51.932